Tenet Healthcare Corporation

• THC Stock Price 24h change: -1.77%. From 196.74 USD to 193.26 USD. The decline was largely driven by broader market volatility, although the stock outperformed the S&P 500's steeper daily loss.
• From a technical perspective, THC is currently showing a short-term bearish signal as it trades below its 20-day moving average. However, the long-term trend remains positive with support found near the $185 level and primary resistance at the $222.82 52-week high; indicators suggest a consolidation phase ahead of the February earnings report.
• Tenet Healthcare (THC) is scheduled to release its Q4 2025 earnings on February 11, 2026, with analysts projecting a 17.73% year-over-year EPS growth.
• A federal court recently moved forward with a lawsuit between Tenet Healthcare and Leapfrog Group, a healthcare quality watchdog, concerning hospital safety ratings.
• TD Cowen recently adjusted its price target for THC to $230 from $233, while maintaining a "Buy" rating based on stable outpatient demand.
• NHS England has launched a "sprint" initiative to drastically reduce elective surgery waiting lists by March 2026, signaling increased operational pressure and funding in the public-private healthcare landscape.
• RBC Capital Markets issued a sector-wide note warning of a challenging 2026 reporting season for healthcare providers due to rising labor costs and competitive threats to revenue growth.

• THC Stock Price 24h change: -1.77%. From 196.74 USD to 193.26 USD.
• The stock's decline was narrower than the S&P 500's 2.06% loss, reflecting some relative resilience despite the downward move. Analysts point to a period of consolidation as the market awaits the Q4 2025 earnings report scheduled for February 11, 2026.
• From a technical perspective, THC is currently in a short-term bearish phase, trading approximately 13% below its 52-week high of $222.81. Key support is identified around the $190-$193 level; a break below this could signal further downside toward the $175 median analyst target. The RSI suggests the stock is approaching oversold territory, which may prompt a "technical bounce" if support holds.
• Tenet Healthcare is scheduled to report its Q4 2025 financial results on February 11, 2026, with analysts expecting an EPS of $4.05, representing a 17.7% year-over-year growth.
• BofA Securities recently adjusted its outlook on Tenet, lifting its price target to $240 while noting that hospitals face moderate headwinds in 2026 due to restrictive policies and shifting fundamentals.
• The 44th Annual J.P. Morgan Healthcare Conference (January 12-15, 2026) concluded in San Francisco, highlighting a major industry shift toward AI integration, including the launch of "Claude for Healthcare" to automate clinical workflows.
• U.S. healthcare CFOs entering 2026 report heightened concerns over external pressures, including rising medical loss ratios (MLRs) and potential tariff-driven cost escalations that could raise procurement expenses by 12-18%.